Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane Pharmacokinetics in Obese ICU Patients
NCT02042612Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sevoflurane, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Plasmatic concentrations of sevoflurane at 48 hours. Started Oct 2013; status: completed.
02
Drugs
sevoflurane
Beyond the preview
Go deeper on NCT02042612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042612.